Fundraising Fox

CoDa Therapeutics

San Diego, US · Delaware corporation · 3 known investors

Find your way into CoDa Therapeutics

Biotech

Founders & leadership

DP
David PoolExecutive
BD
Bradford DuftinPresident and CEOformer

Board

JB
James BlairinBoard directorPartner at Domain Associates
GB
Geoff BrookeBoard director
JM
James MervisBoard director
MG
Mikhail GetmanBoard director
AG
Anton GopkaBoard director
""
"Howard ""Ted""" GreeneBoard director

Investors · 3

Domain AssociatesreportedPrinceton · $200K – $15M
MPM BioImpactreportedBoston · $1M – $15M
Novartis Venture FundreportedBasel · $5M – $25M

Reported raises · per SEC filings

Form D private placements

$14.6M disclosed across 5 rounds · 2014–2020

▶$9.1MraisedJan 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian LevyExecutive Officer, Director
  • Pavel RodyukovDirector
  • James BlairDirector
  • David PoolExecutive Officer
Offering amount
$9.1M
Amount sold
$9.1M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$754KraisedJun 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoff BrookeDirector
  • David PoolExecutive Officer
  • James MervisDirector
  • Bradford DuftExecutive Officer, Director
  • "Howard ""Ted""" GreeneDirector
  • James BlairDirector
  • Inna Martin EitanDirector
Offering amount
$2.5M
Amount sold
$754K
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJun 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • "Howard ""Ted""" GreeneDirector
  • David PoolExecutive Officer
  • James MervisDirector
  • James BlairDirector
  • Bradford DuftExecutive Officer, Director
  • Geoff BrookeDirector
  • Inna Martin EitanDirector
Offering amount
$3.4M
Amount sold
$1.2M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedFeb 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • "Howard ""Ted""" GreeneDirector
  • James BlairDirector
  • David PoolExecutive Officer
  • Geoff BrookeDirector
  • Bradford DuftExecutive Officer, Director
  • James MervisDirector
  • Mikhail GetmanDirector
Offering amount
$3.2M
Amount sold
$1M
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJun 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James BlairDirector
  • David PoolExecutive Officer
  • Bradford DuftExecutive Officer, Director
  • Geoff BrookeDirector
  • James MervisDirector
  • "Howard ""Ted""" GreeneDirector
  • Anton GopkaDirector
Offering amount
$5.8M
Amount sold
$2.5M
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

CoDa Therapeutics Completes $40 Million Series B Equity Financing | Fierce Biotechfiercebiotech.com · Jul 2012CoDa Therapeutics, Inc. Announces $10 Million Series A Financing - BioSpacebiospace.com · Oct 2006CoDa Therapeutics - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

Who are CoDa Therapeutics's investors?
CoDa Therapeutics's investors include Domain Associates, MPM BioImpact, Novartis Venture Fund.
How much funding has CoDa Therapeutics raised?
CoDa Therapeutics has disclosed $14.6M raised across 5 rounds.
Where is CoDa Therapeutics headquartered?
CoDa Therapeutics is headquartered in San Diego, US.